Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Fully humanized anti-platelet factor 4 antibodies that treat heparin-induced thrombocytopenia

Fully humanized anti-platelet factor 4 antibodies that treat heparin-induced thrombocytopenia

US Patent 12304948 · Granted May 20, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-tumor compound and preparation method and use thereof2025
Location precision techniques for enhanced depth data in wireless communications2025
Dynamic, comprehensive, and intelligent integration of telecommunication network2025
Distributed computing across a wireless communications network2025
Radio access network (RAN) data exposure in a wireless communication network2025
Atomic description of immune complex that causes heparin-induced thrombocytopeni2025
Atomic description of immune complex that causes heparin-induced thrombocytopeni2025
Atomic description of immune complex that causes heparin-induced thrombocytopeni2025
Atomic description of immune complex that causes heparin-induced thrombocytopeni2025
Slices for applications based on multiple active SIM profiles2025
Configuring ad hoc content servers based on server load limits2025
System and method for provisioning multiple network slices for concurrent use by2025